4-[(Piperidin-4-yl)methyl]morpholine → HCID 66715423, 화합물

HRID 2271585노트

반응식

HRID 2271585 반응식
[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2Cl.[NH:18]1[CH2:23][CH2:22][CH:21]([CH2:24][N:25]2[CH2:30][CH2:29][O:28][CH2:27][CH2:26]2)[CH2:20][CH2:19]1>>[Br:1][C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[N:18]1[CH2:23][CH2:22][CH:21]([CH2:24][N:25]2[CH2:30][CH2:29][O:28][CH2:27][CH2:26]2)[CH2:20][CH2:19]1

참가 물질

3

반응물 2

HCID 128029064-[(Piperidin-4-yl)methyl]morpholineHCID 66715111(6-Bromo-4-chloroquinolin-3-yl)(cyclopropyl)methanone

생성물 1

HCID 66715423HCID 66715423, 화합물수율 84%

실험 절차

Following general procedure B, (6-bromo-4-chloroquinolin-3-yl)(cyclopropyl)methanone (144 mg, 0.460 mmol) was reacted with 4-(piperidin-4-ylmethyl)morpholine (102 mg, 0.552 mmol) to afford the desired product (177 mg, 84%) as a yellow solid: ESI MS m/z 458 [C23H28BrN3O2+H]+.

출처 및 근거

ORD 기록
ord-0bd46e9bfc104d9bbc3dc79b586ac1d9
출처 데이터셋
uspto-grants-2015_09
특허 번호
US09120749B2

반응 노트

불러오는 중…